Viewing Study NCT07239102


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2025-12-26 @ 2:32 AM
Study NCT ID: NCT07239102
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2025-11-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Sponsor: Beijing Tiantan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module